FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1252-1253 March 18, 2004 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

A fundamental question of cancer genetics is how genes responsible for inherited cancer contribute to the far more frequent cases of cancer that are purely somatic in origin. Somatic mutations in p53 in a vast range of tumors are similar to inherited germ-line mutations in the p53 tumor-suppressor gene in families with the Li–Fraumeni syndrome and were discovered at about the same time. But the roles of other inherited cancer genes in somatic tumorigenesis have been more difficult to define. Biochemistry has come to the rescue of genetics in this effort. Binding partners of the proteins encoded by cancer genes . . . [Full Text of this Article]

Source Information

From the Departments of Medicine (Medical Genetics) and Genome Sciences, University of Washington, Seattle.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.